Cyamemazine tartrate
- Level
- Commodity
- Parent
- 51332800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332846This classification denotes a histamine-1 receptor antagonist C19H21N3S.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C4ZT3BE459, chemically known as 10h-phenothiazine-2-carbonitrile, 10-(3-(dimethylamino)-2-methylpropyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1), but more generally known as cyamemazine tartrate, which bears US NIH Compound Identifier 24892868. European Medicines Agency schedules Cyamemazine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01510MIG. Most nations, for tariff and trade purposes, schedule cyamemazine tartrate under HS 29343090 and SITC 51578. As of Q4 2014, CYAMEMAZINE TARTRATE remains US FDA's Preferred Term for this commodity. SMILES: CC(CN1C2CCCCC2SC3C1CC(CC3)C#N)CN(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.
Same parent
Under 51332800 · 79Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.